FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook
FMC Corporation reported Q3 2026 revenue of $106M, down $436M YoY, with a $639M negative impact from commercial actions. GAAP net loss was $2.07B, and adjusted EBITDA was negative $559M. The company revised its Q4 outlook, expecting revenue of $1.04B-$1.14B and adjusted EBITDA of $210M-$230M, both down YoY. Full-year free cash flow is now expected to be negative $350M to negative $150M.
How this was made
The 30-second read
Why it matters
Q3 results show severe GAAP and Adjusted EBITDA deterioration largely attributable to the commercial actions, while the revised Q4 outlook lowers Adjusted EBITDA and Adjusted EPS and keeps full-year free cash flow negative.
Market read
Traders get a fresh, quantified earnings and cash-flow outlook update tied to an ongoing pricing/rebate transition, which is likely to drive near-term positioning.
What to watch
The outlook is ex-India and assumes volume growth from direct-to-grower sales in Brazil and new products; deviations in those drivers could widen the gap versus the stated EBITDA/EPS ranges.
Background
FMC previously announced Oct. 15 commercial actions to modify North America pricing and rebate mechanics and adjust higher-priced channel inventory products.
Ticker impact
FMC reported Q3 2026 results and revised Q4 outlook, including a $639M revenue and $672M Adjusted EBITDA hit from Oct. 15 commercial actions.
Likely downside bias as traders price in lower Q4 EBITDA/EPS and the drag from ongoing pricing and rebate model implementation.
The article provides concrete Q4 ranges (revenue ex-India, Adjusted EBITDA, Adjusted EPS) and ties the bulk of the Q3 deterioration to the previously announced commercial actions that are still transitioning over the next three quarters.
Market effects
Signals ongoing pricing and channel-inventory management stress in ag-chemical/inputs demand, which can pressure sentiment across similar inventory-heavy peers.
North America channel inventory and rebate-model transition are central, with Brazil direct-to-grower sales cited as a partial offset.
FX is explicitly cited as a headwind, so currency moves may amplify or dampen FMC’s near-term earnings trajectory.
Counterpoint
The company frames the commercial actions as a necessary reset to reduce channel inventory volatility, which could improve 2027 performance if execution stays on track.
Key entities
- companyFMC Corporation
NYSE-listed ag-chemical company reporting Q3 2026 results and revising Q4 and full-year 2026 outlook, including impacts from pricing and rebate commercial actions.
- investorTessenderlo Group
Referenced as having closed an investment in September that increased FMC’s share count, affecting Adjusted EPS.
